Definitive Contract 75N93022C00009
Award Date
5/30/22
Potential Completion Date
5/29/29
Potential Value
$18M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
The Research Foundation For The State University Of New York
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Buffalo, NY 14228, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $11,728,252.94 indefinite delivery contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to The Research Foundation for the State University of New York (RF SUNY) for Clinical Pharmacology Quality Assurance services. The contract has no set-aside designation. RF SUNY, a non-profit organization, is the prime contractor and has subcontracted with Frontier Science & Technology Research Foundation,...
This is a cost-plus-award-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, titled "NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)", has a ceiling value of $342,278,815.66 and a period of performance ending on August 15, 2024. The contract was awarded...
This is a federal contract award to Bioqual Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services. The contract is for biomedical management and support services and has a ceiling value of $25,914,588.55. The contract type is Cost Plus Fixed Fee, and the period of performance runs from March 1, 2001 to June 10, 2008. The contract is a definitive contract and does not have a set-aside designation. The place of...
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, valued at $66,339,562.95, is for the TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER and has a performance period ending on February 23, 2023. PPD Development LP, a subsidiary of Thermo Fisher...
This is a federal contract award to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract, valued at $139,861,060.22, is for NIAID Clinical Site Monitoring services. This is a definitive contract with a cost-plus-fixed-fee pricing type, with a period of performance through January 31, 2024. The...
This is a $29,120,381 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to PPD Development LP, a global contract research organization (CRO). The contract is for the Regulatory Management Center (RMC), which provides regulatory affairs support services. This contract has no set-aside designation. The original solicitation was a Sources Sought notice seeking small business capability...
This is a federal contract award to Pharmaron, Inc., a global contract research organization (CRO) specializing in preclinical research services for the pharmaceutical and biotechnology industries, as well as government agencies. The contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), and is part of the NIH Bioanalysis Testing Services 2015-2020 master indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract...
This is a $86,835,067.00 definitive, cost-plus-fixed-fee contract awarded to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract is for the Clinical Research Products Development Center (CRPDC), which provides pharmaceutical services and study product management for NIAID-sponsored clinical research trials, with a focus on HIV/AIDS and related conditions. The services include cGMP-compliant...
This is a $5,758,524.34 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to PPD Development LP, a global contract research organization (CRO). The contract is to provide monitoring services for a Phase III clinical trial, specifically trial A5300B/PHOENIX. It is a cost-plus-fixed-fee contract with an ultimate completion date of December 14, 2025. The contract was awarded on April 15, 2019 and is not...
This federal contract award is for QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUPPORT services. The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit organization and manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The contract has a ceiling value of $6,169,389.00 and a completion date of April 14, 2030. It is a delivery order contract type with a cost-plus-fixed-fee pricing structure. The contract is...